Cargando…
Timings for HbA(1c) testing in people with diabetes are associated with incentive payments: an analysis of UK primary care data
AIMS: Guidelines recommend testing HbA(1c) every 3–6 months in people with diabetes. In the United Kingdom (UK), primary care clinics are financially incentivized to monitor HbA(1c) at least annually and report proportions of patients meeting targets on 31 March. We explored the hypothesis that this...
Autores principales: | Hirst, J. A., Farmer, A. J., Smith, M. C., Stevens, R. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519368/ https://www.ncbi.nlm.nih.gov/pubmed/30175871 http://dx.doi.org/10.1111/dme.13810 |
Ejemplares similares
-
How point‐of‐care HbA(1c) testing changes the behaviour of people with diabetes and clinicians – a qualitative study
por: Hirst, J. A., et al.
Publicado: (2020) -
Estimating the effect of sulfonylurea on HbA(1c) in diabetes: a systematic review and meta-analysis
por: Hirst, J. A., et al.
Publicado: (2013) -
Changes in HbA1c Level over a 12-Week Follow-up in Patients with Type 2 Diabetes following a Medication Change
por: Hirst, Jennifer A., et al.
Publicado: (2014) -
Point-of-care HbA(1c) testing in an urban primary care diabetes clinic in South Africa: a mixed methods feasibility study
por: Hirst, Jennifer A, et al.
Publicado: (2021) -
Utility of HbA(1c) assessment in people with diabetes awaiting liver transplantation
por: Bhattacharjee, D., et al.
Publicado: (2019)